Cochlear implantation for treatment-induced ototoxic deafness in Langerhans cell histiocytosis. A case report

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 6, 2005, Pages 496-500

  Torkos, Attila ^a   Czigner, Jeno ^a   Kiss, József Géza ^a   Tóth, Ferenc ^a   Szamosközi, Alice ^a   Jóri, József ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Chemotherapy; Cochlear implantation; Histiocytosis; Ototoxicity; Postlingual deafness

Indexed keywords

CYTOSTATIC AGENT; ETOPOSIDE; MERCAPTOPURINE; PREDNISONE; VINBLASTINE;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD DEVELOPMENT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEMALE; HEARING AID; HISTIOCYTOSIS X; HUMAN; IMPLANTATION; LONG TERM CARE; MEDICAL EXAMINATION; OTOTOXICITY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; FEMALE; HEARING LOSS, BILATERAL; HEARING LOSS, SENSORINEURAL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; SPEECH PERCEPTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 21344464674     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-004-0858-1     Document Type: Article

References (16)

1. Bokemeyer C, Berger C C, Kuczyk M A, Schmoll H J (1996) Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14:2923-2932
2. Cronin S, Uberti J P, Ayash L J, Raith C, Ratanatharathorn V (2000) Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 26:1247-1249
3. Formanek M, Czerny C, Gstoettner W, Kornfehl J (1998) Cochlear implantation as a successful rehabilitation for radiation induced deafness. Eur Arch Otorhinolaryngol 255:175-178
4. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S (1994) Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 23:72-80
5. Gray R F, Jones S E M, Court I (2003) Cochlear implantation for progressive hearing loss. Arch Dis Child 88:708-711
6. Jaffe E S, Harris N L, Stein H, Vardiman J W (2001) Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, p 280
7. Lee J S, Lee D S, Oh S H, Kim C S, Kim J, Hwang C H, Koo J, Kang E, Chung J, Lee M C (2003) PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med 9:1435-1439
8. Lehnhardt E (1994) Das Cochlearimplantat bei Kindern: Indikation und chirurgische Aspekte. Wien Med Wochenschr 144:8-14
9. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H (2000) Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. Klin Padiatr 212:139-144
10. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H (2002) Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 39:581-585
11. Moss P E, Hickman S, Harrison B R (1999) Ototoxicity associated with vinblastine. Ann Pharmacother 33:423-425
12. Perin G, Dallorso S, Stura M, Moroni C, Rogers D, Dini G, De Bernardi B (1987) High-dose cisplatin and etoposide in advanced malignancies of childhood. Pediatr Hematol Oncol 4:329-336
13. Ponton CW, Moore JK, Eggermont JJ (1999) Prolonged deafness limits auditory system developmental plasticity: evidence from an evoked potentials study in children with cochlear implants. Scand Audiol [Suppl] 51:13-22
14. Schweitzer VG (1993) Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 26:759-789
15. Sweeney C (2001) History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity. Semin Urol Oncol 19:170-179
16. Torkos A, Jóri J, Tóth F, Szamosközi A, Kiss J G, Czigner J (2002) Successful cochlear implantation in a child after recovery from a head and neck malignancy: a case report. Eur Arch Otorhinolaryngol 259:343-346